{"id":"https://openalex.org/W2051291954","doi":"https://doi.org/10.4161/mabs.2.5.12897","title":"Assessing monoclonal antibody product quality attribute criticality through clinical studies","display_name":"Assessing monoclonal antibody product quality attribute criticality through clinical studies","alternate_titles":[],"publication_year":2010,"publication_date":"2010-09-01","ids":{"openalex":"https://openalex.org/W2051291954","doi":"https://doi.org/10.4161/mabs.2.5.12897","mag":"2051291954","pmid":"https://pubmed.ncbi.nlm.nih.gov/20671426","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2958571"},"language":"en","primary_location":{"id":"doi:10.4161/mabs.2.5.12897","doi":"https://doi.org/10.4161/mabs.2.5.12897","is_oa":true,"landing_page_url":"https://doi.org/10.4161/mabs.2.5.12897","pdf_url":"https://www.tandfonline.com/doi/pdf/10.4161/mabs.2.5.12897?needAccess=true","source":{"id":"https://openalex.org/S169123381","display_name":"mAbs","issn_l":"1942-0862","issn":["1942-0862","1942-0870"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2051291954"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.tandfonline.com/doi/pdf/10.4161/mabs.2.5.12897?needAccess=true","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110449921","display_name":"Andrew M. Goetze","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Andrew M. Goetze","raw_affiliation_strings":["Department of Process and Product Development, Amgen Inc., Thousand Oaks, CA, USA","Amgen Inc","Thousand Oaks, CA USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Process and Product Development, Amgen Inc., Thousand Oaks, CA, USA","institution_ids":["https://openalex.org/I1320553840"]},{"raw_affiliation_string":"Amgen Inc","institution_ids":["https://openalex.org/I1320553840"]},{"raw_affiliation_string":"Thousand Oaks, CA USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053183853","display_name":"Matthew R. Schenauer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Matthew R. Schenauer","raw_affiliation_strings":["Department of Process and Product Development; Amgen Inc.; Thousand Oaks, CA USA","Amgen Inc","Department of Process and Product Development","Thousand Oaks, CA USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Process and Product Development; Amgen Inc.; Thousand Oaks, CA USA","institution_ids":["https://openalex.org/I1320553840"]},{"raw_affiliation_string":"Amgen Inc","institution_ids":["https://openalex.org/I1320553840"]},{"raw_affiliation_string":"Department of Process and Product Development","institution_ids":[]},{"raw_affiliation_string":"Thousand Oaks, CA USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5035284210","display_name":"Gregory C. Flynn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Gregory C. Flynn","raw_affiliation_strings":["Department of Process and Product Development; Amgen Inc.; Thousand Oaks, CA USA","Amgen Inc","Department of Process and Product Development","Thousand Oaks, CA USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Process and Product Development; Amgen Inc.; Thousand Oaks, CA USA","institution_ids":["https://openalex.org/I1320553840"]},{"raw_affiliation_string":"Amgen Inc","institution_ids":["https://openalex.org/I1320553840"]},{"raw_affiliation_string":"Department of Process and Product Development","institution_ids":[]},{"raw_affiliation_string":"Thousand Oaks, CA USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5035284210"],"corresponding_institution_ids":["https://openalex.org/I1320553840"],"apc_list":{"value":2915,"currency":"GBP","value_usd":3575},"apc_paid":{"value":2915,"currency":"GBP","value_usd":3575},"fwci":0.4425,"has_fulltext":true,"cited_by_count":115,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.41982665,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"2","issue":"5","first_page":"500","last_page":"507"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.5737000107765198,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.5737000107765198,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.40700000524520874,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.014700000174343586,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.9879999756813049},{"id":"https://openalex.org/keywords/critical-quality-attributes","display_name":"critical quality attributes","score":0.9810000061988831},{"id":"https://openalex.org/keywords/recombinant-therapeutic-proteins","display_name":"recombinant therapeutic proteins","score":0.8460000157356262},{"id":"https://openalex.org/keywords/protein-heterogeneity","display_name":"protein heterogeneity","score":0.6579999923706055},{"id":"https://openalex.org/keywords/drug-clearance","display_name":"drug clearance","score":0.5920000076293945},{"id":"https://openalex.org/keywords/clinical-samples","display_name":"clinical samples","score":0.5329999923706055},{"id":"https://openalex.org/keywords/bioactivity","display_name":"biological activity","score":0.5099999904632568}],"concepts":[{"id":"https://openalex.org/C125611927","wikidata":"https://www.wikidata.org/wiki/Q17008131","display_name":"Criticality","level":2,"score":0.7975552678108215},{"id":"https://openalex.org/C183696295","wikidata":"https://www.wikidata.org/wiki/Q2487696","display_name":"Biochemical engineering","level":1,"score":0.6602814793586731},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.5190101861953735},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.49591192603111267},{"id":"https://openalex.org/C2779530757","wikidata":"https://www.wikidata.org/wiki/Q1207505","display_name":"Quality (philosophy)","level":2,"score":0.48281487822532654},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4823879301548004},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.45928263664245605},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.45415109395980835},{"id":"https://openalex.org/C98045186","wikidata":"https://www.wikidata.org/wiki/Q205663","display_name":"Process (computing)","level":2,"score":0.4379793703556061},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.4328697621822357},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.4032459855079651},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.31484103202819824},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.2706966996192932},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2692982256412506},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.24891608953475952},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.20916315913200378},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1957959532737732},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.15751782059669495},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.08194327354431152},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0},{"id":"https://openalex.org/C185544564","wikidata":"https://www.wikidata.org/wiki/Q81197","display_name":"Nuclear physics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C111919701","wikidata":"https://www.wikidata.org/wiki/Q9135","display_name":"Operating system","level":1,"score":0.0},{"id":"https://openalex.org/C111472728","wikidata":"https://www.wikidata.org/wiki/Q9471","display_name":"Epistemology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D035843","descriptor_name":"Biomedical Research","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.4161/mabs.2.5.12897","doi":"https://doi.org/10.4161/mabs.2.5.12897","is_oa":true,"landing_page_url":"https://doi.org/10.4161/mabs.2.5.12897","pdf_url":"https://www.tandfonline.com/doi/pdf/10.4161/mabs.2.5.12897?needAccess=true","source":{"id":"https://openalex.org/S169123381","display_name":"mAbs","issn_l":"1942-0862","issn":["1942-0862","1942-0870"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2171134","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2958571","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:2958571","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2958571/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"MAbs","raw_type":"Text"},{"id":"pmid:20671426","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20671426","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.4161/mabs.2.5.12897","doi":"https://doi.org/10.4161/mabs.2.5.12897","is_oa":true,"landing_page_url":"https://doi.org/10.4161/mabs.2.5.12897","pdf_url":"https://www.tandfonline.com/doi/pdf/10.4161/mabs.2.5.12897?needAccess=true","source":{"id":"https://openalex.org/S169123381","display_name":"mAbs","issn_l":"1942-0862","issn":["1942-0862","1942-0870"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8048999905586243}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2051291954.pdf","grobid_xml":"https://content.openalex.org/works/W2051291954.grobid-xml"},"referenced_works_count":33,"referenced_works":["https://openalex.org/W1482002790","https://openalex.org/W1657453984","https://openalex.org/W1967265624","https://openalex.org/W1968037422","https://openalex.org/W1979741421","https://openalex.org/W1980650956","https://openalex.org/W1989801492","https://openalex.org/W2000144429","https://openalex.org/W2001756598","https://openalex.org/W2004290717","https://openalex.org/W2009383936","https://openalex.org/W2018795884","https://openalex.org/W2048814278","https://openalex.org/W2051995022","https://openalex.org/W2063232995","https://openalex.org/W2071186866","https://openalex.org/W2071843728","https://openalex.org/W2073948759","https://openalex.org/W2084180910","https://openalex.org/W2085729628","https://openalex.org/W2089644524","https://openalex.org/W2090618368","https://openalex.org/W2091251425","https://openalex.org/W2106183724","https://openalex.org/W2113701404","https://openalex.org/W2118540273","https://openalex.org/W2119562248","https://openalex.org/W2151682079","https://openalex.org/W2168236041","https://openalex.org/W2250059298","https://openalex.org/W3004335124","https://openalex.org/W4233249586","https://openalex.org/W4245548411"],"related_works":["https://openalex.org/W2341057106","https://openalex.org/W2915850944","https://openalex.org/W2896810650","https://openalex.org/W2326175764","https://openalex.org/W4306155891","https://openalex.org/W2030899178","https://openalex.org/W2498896723","https://openalex.org/W2791987218","https://openalex.org/W7055563026","https://openalex.org/W2460911099"],"abstract_inverted_index":{"Recombinant":[0],"therapeutic":[1,73],"proteins,":[2],"including":[3],"antibodies,":[4],"contain":[5],"a":[6,156],"variety":[7],"of":[8,44,62,72,123,155],"chemical":[9,46,181],"and":[10,19,24,52,68,82,99,150,167],"physical":[11],"modifications.":[12],"Great":[13],"effort":[14],"is":[15,105,126],"expended":[16],"during":[17,165],"process":[18],"formulation":[20],"development":[21],"in":[22,50,117,131],"controlling":[23],"minimizing":[25],"this":[26,88],"heterogeneity,":[27],"which":[28],"may":[29,37,77,141],"not":[30,38],"affect":[31,78,146],"safety":[32,147],"or":[33,148,183],"efficacy,":[34],"and,":[35],"therefore,":[36],"need":[39],"to":[40,60,107,120,145,180],"be":[41,58,163],"controlled.":[42],"Many":[43],"the":[45,55,63,69,79,121,127,153,170],"conversions":[47],"also":[48],"occur":[49],"vivo,":[51],"knowledge":[53],"about":[54],"alterations":[56],"can":[57],"applied":[59,106],"assessment":[61],"potential":[64,144],"impact":[65],"on":[66,174],"characteristics":[67],"biological":[70],"activity":[71],"proteins.":[74],"Other":[75],"attributes":[76,115],"drug":[80,85],"clearance":[81],"thereby":[83,151],"alter":[84],"efficacy.":[86],"In":[87,111],"review":[89],"article,":[90],"we":[91],"describe":[92],"attribute":[93,108,135],"studies":[94],"conducted":[95],"using":[96],"clinical":[97],"samples":[98],"how":[100,113],"information":[101],"gleaned":[102],"from":[103],"them":[104],"criticality":[109],"assessment.":[110],"general,":[112],"fast":[114],"change":[116],"vivo":[118],"compared":[119],"rate":[122],"mAb":[124],"elimination":[125],"key":[128],"parameter":[129],"used":[130],"these":[132],"evaluations.":[133],"An":[134],"with":[136],"more":[137],"rapidly":[138],"changing":[139],"levels":[140],"have":[142],"greater":[143],"efficacy":[149],"reach":[152],"status":[154],"Critical":[157],"Quality":[158],"Attribute":[159],"(CQA)":[160],"that":[161],"should":[162],"controlled":[164],"production":[166],"storage,":[168],"but":[169],"effect":[171],"will":[172],"depend":[173],"whether":[175],"compositional":[176],"changes":[177],"are":[178],"due":[179],"conversion":[182],"differential":[184],"clearance.":[185]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2051291954","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":14},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
